"A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitis*." Clinical Toxicology, 57(6), pp. 421–422
No takes yet. Share an insight, caveat, or question.
Zahran et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: